Aurora Cannabis (TSE:ACB) Releases Earnings Results

Aurora Cannabis (TSE:ACB) announced its earnings results on Thursday. The company reported C($0.99) earnings per share (EPS) for the quarter, FiscalAI reports. Aurora Cannabis had a negative return on equity of 7.25% and a negative net margin of 12.13%.The company had revenue of C$38.01 million for the quarter.

Aurora Cannabis Trading Down 0.7%

Aurora Cannabis stock opened at C$4.25 on Friday. Aurora Cannabis has a 52 week low of C$3.77 and a 52 week high of C$9.33. The company has a debt-to-equity ratio of 4.66, a quick ratio of 2.48 and a current ratio of 5.94. The firm has a market capitalization of C$251.29 million, a price-to-earnings ratio of -2.83 and a beta of 0.17. The company has a 50 day moving average price of C$4.76 and a 200 day moving average price of C$5.30.

Analyst Ratings Changes

A number of equities analysts recently commented on ACB shares. TD decreased their price objective on shares of Aurora Cannabis to C$8.00 and set a “buy” rating for the company in a research note on Friday. Canaccord Genuity Group decreased their price objective on shares of Aurora Cannabis from C$8.00 to C$6.50 and set a “buy” rating for the company in a research note on Friday. Three research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of C$7.67.

About Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.